The Globe and Mail reports in its Friday, Oct. 11, edition that ATB Capital Markets analyst Frederico Gomes is sticking with his "sector perform" recommendation for Tilray Brands. The Globe's David Leeder writes that Mr. Gomes gave his share target a 25-cent trim to $2 (all figures U.S.). Analysts on average target the shares at $2.25. Mr. Gomes says in a note: "Tilray is ambitiously growing its beverage platform with the recent $23.1-million acquisition of Molson Coors' craft beer brands, and investments into new categories, including to enter the U.S. hemp-derived THC beverage market. ... We like the move into hemp-derived THC as a potential new growth vector, but we remain generally cautious on M&A as a value driver (we think more M&A in beverages may come). Meanwhile, we expect the LP market to remain challenging, notably as industry growth slows (here); as such, we expect growth in cannabis to be driven mostly by international. Since FY2024 end, we estimate Tilray has added approximately 8.6 per cent to its basic shares outstanding as a result of its ATM program, debt repurchases, and other transactions. We maintain our neutral stance on Tilray as our growth expectations are largely priced in."